Get started
RESMED INCRESMED INCRESMED INC

RESMED INC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Forecast Seasonals

RME chart


Full chart

RME upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪25.93 B‬ CHF
Dividend yield (indicated)
0.99%
Price to earnings Ratio (TTM)
25.861
Basic EPS (TTM)
7.721 CHF
Net income (FY)
‪917.87 M‬ CHF
Revenue (FY)
‪4.21 B‬ CHF
Shares float
‪145.81 M‬
Beta (1Y)
0.78

Employees


Employees (FY)
‪9.98 K‬
Change (1Y)
−160 −1.58%
Revenue / Employee (1Y)
‪422.07 K‬ CHF
Net income / Employee (1Y)
‪91.97 K‬ CHF

About ResMed Inc.


Sector
Health Technology
Industry
Medical Specialties
CEO
Michael J. Farrell
Website
resmed.com
Headquarters
San Diego
Founded
1989
FIGI
BBG00LVG9KJ9
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. The firm operates through the Sleep and Respiratory Care and Software as a Service segments. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The Software as a Service segment provides business management software as a service to out-of-hospital health providers. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

RME news



Ideas



See all ideas 

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as RME.

Frequently Asked Questions


The current price of RME is 177.637 CHF — it has decreased by −0.67% in the past 24 hours. Watch RESMED INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange RESMED INC stocks are traded under the ticker RME.
RME stock has fallen by −0.67% compared to the previous week, the month change is a −0.67% fall, over the last year RESMED INC has showed a −0.67% decrease.
We've gathered analysts' opinions on RESMED INC future price: according to them, RME price has a max estimate of 241.78 CHF and a min estimate of 160.81 CHF. Watch RME chart and read a more detailed RESMED INC stock forecast: see what analysts think of RESMED INC and suggest that you do with its stocks.
RME reached its all-time high on Sep 7, 2021 with the price of 273.388 CHF, and its all-time low was 129.531 CHF and was reached on Nov 14, 2023. View more price dynamics on RME chart.
See other stocks reaching their highest and lowest prices.
RME stock is 0.67% volatile and has beta coefficient of 0.78. Track RESMED INC stock price on the chart and check out the list of the most volatile stocks — is RESMED INC there?
Today RESMED INC has the market capitalization of ‪25.93 B‬, it has increased by 1.27% over the last week.
Yes, you can track RESMED INC financials in yearly and quarterly reports right on TradingView.
RESMED INC is going to release the next earnings report on Apr 23, 2025. Keep track of upcoming events with our Earnings Calendar.
RME earnings for the last quarter are 2.21 CHF per share, whereas the estimation was 2.10 CHF resulting in a 4.94% surprise. The estimated earnings for the next quarter are 2.11 CHF per share. See more details about RESMED INC earnings.
RESMED INC revenue for the last quarter amounts to ‪1.16 B‬ CHF, despite the estimated figure of ‪1.15 B‬ CHF. In the next quarter, revenue is expected to reach ‪1.14 B‬ CHF.
RME net income for the last quarter is ‪312.99 M‬ CHF, while the quarter before that showed ‪263.85 M‬ CHF of net income which accounts for 18.62% change. Track more RESMED INC financial stats to get the full picture.
Yes, RME dividends are paid quarterly. The last dividend per share was 0.48 CHF. As of today, Dividend Yield (TTM)% is 0.97%. Tracking RESMED INC dividends might help you take more informed decisions.
RESMED INC dividend yield was 1.00% in 2024, and payout ratio reached 27.75%. The year before the numbers were 0.81% and 28.91% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 23, 2025, the company has ‪9.98 K‬ employees. See our rating of the largest employees — is RESMED INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RESMED INC EBITDA is ‪1.62 B‬ CHF, and current EBITDA margin is 34.16%. See more stats in RESMED INC financial statements.
Like other stocks, RME shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RESMED INC stock right from TradingView charts — choose your broker and connect to your account.